What's Happening?
FairJourney Bio, a global antibody discovery contract research organization, has opened a new cryo-electron microscopy (cryo-EM) structural biology facility in San Diego, California. This facility is equipped with state-of-the-art 300 kV cryo-EM infrastructure,
including ThermoFisher Titan Krios systems, enabling high-resolution structure determination of antibody-target complexes. The facility aims to integrate atomic-resolution structural biology into the antibody discovery process, providing detailed insights from epitope mapping to candidate selection. The launch marks a significant expansion of FairJourney Bio's presence in the U.S. biotech market.
Why It's Important?
The establishment of this cryo-EM facility represents a major advancement in the field of structural biology and antibody discovery. By incorporating high-resolution structural insights early in the discovery process, FairJourney Bio aims to improve the efficiency and success rate of antibody development. This approach can lead to more effective therapeutics and accelerate the drug discovery timeline. The facility's location in San Diego, a major biotech hub, positions FairJourney Bio to collaborate with leading research institutions and biotech companies, further enhancing its impact on the industry.
What's Next?
With the new facility operational, FairJourney Bio plans to leverage its capabilities to support a wide range of antibody discovery projects. The company is likely to engage in collaborations with academic and industry partners to explore new therapeutic targets and optimize drug candidates. The integration of cryo-EM into the discovery workflow may also inspire other organizations to adopt similar approaches, potentially transforming the landscape of structural biology and drug development. Ongoing advancements in cryo-EM technology could further enhance the facility's capabilities and expand its applications.
